• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7961102).
  

PubMed=2208167
Yamaguchi N., Yamamura Y., Koyama K., Ohtsuji E., Imanishi J., Ashihara T.
Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium.
Cancer Res. 50:7008-7014(1990)

PubMed=7961102; DOI=10.1111/j.1349-7006.1994.tb02898.x; PMCID=PMC5919355
Suwa H., Yoshimura T., Yamaguchi N., Kanehira K., Manabe T., Imamura M., Hiai H., Fukumoto M.
K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.
Jpn. J. Cancer Res. 85:1005-1014(1994)

PubMed=8288629; DOI=10.1016/S0021-9258(17)42180-6
Yamaguchi N., Hattori K., Oh-eda M., Kojima T., Imai N., Ochi N.
A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5.
J. Biol. Chem. 269:805-808(1994)

DOI=10.4172/2324-9293.1000104
Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R., Saeger H.-D.
Distribution of characteristic mutations in native ductal adenocarcinoma of the pancreas and pancreatic cancer cell lines.
Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013)